Mode
Text Size
Log in / Sign up
N/A Completed N=30 Diagnostic

KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer

Liver Cancer · Pancreatic Cancer · Prostate Carcinoma
Source: ClinicalTrials.gov NCT02337465 ↗
Enrolled (actual)
30
Serious AEs
Results posted
Feb 2021
Primary outcomePrimary: Percentage of Ultrasound Images Which Are Clinically Adequate for Treatment Set-up — 100 Percent of images

Summary

This clinical trial studies if kilo-voltage cone beam computed tomography (KV-CBCT) and ultrasound imaging works in guiding radiation therapy in patients with prostate, liver, or pancreatic cancer. Computer systems, such as KV-CBCT and ultrasound imaging, allow doctors to create a 3-dimensional picture of the tumor may help in planning radiation therapy and may result in more tumor cells being killed.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Ultrasound Images Which Are Clinically Adequate for Treatment Set-up
100
PRIMARY
Number of Participants Able to Have the Ultrasound Probe Attached During the Entire Treatment Course
29
PRIMARY
Percent of Patients Whose Plan Quality Was Not Not Affected in the Presence of the Ultrasound Probe
100

Eligibility Criteria

Inclusion Criteria

  • The patient must have either 1) cancer involving the liver by biopsy or radiographic criteria, or 2) prostate cancer by biopsy, with the intent of undergoing definitive dose radiation therapy to targets within the liver, or prostate. Patients with prostatectomy receiving post-operative radiotherapy are also eligible.
  • Karnofsky performance status (PS) ≥ 70
  • Subjects must have the ability to understand and the willingness to sign a written informational form

Exclusion Criteria

  • Patients with uncontrolled inter-current illness or psychiatric illness/social situations that would limit compliance with study requirements
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02337465). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search